19/08/2026
WHEN MEDICINES RUN OUT, WHO PAYS THE PRICE?
TB patients are facing delays and treatment interruptions as public health centers run short of anti-TB medicines.
In interviews with Probe Productions, health professionals and community workers described what happens when supplies run out: patients may have to wait, look elsewhere for medicines or pay out of pocket.
The stakes are higher when treatment is interrupted. TB can return, become drug-resistant and continue spreading.
Swipe through our 3-card explainer to see how the shortage affects treatment, why interruptions matter and what patients are being left to shoulder.
Check comments for story.